Edition:
United Kingdom

ContraFect Corp (CFRX.OQ)

CFRX.OQ on NASDAQ Stock Exchange Capital Market

2.08USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$2.08
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
37,443
52-wk High
$2.90
52-wk Low
$0.90

Chart for

About

ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Its pipeline of lysin... (more)

Overall

Beta: --
Market Cap(Mil.): $95.02
Shares Outstanding(Mil.): 73.66
Dividend: --
Yield (%): --

Financials

  CFRX.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -0.49 -- --
ROI: -104.45 9.01 14.96
ROE: -153.83 10.15 16.52

Earnings vs. Estimates